Could or Should We Use MCDA in the French HTA Process?

Salah Ghabri, Jean-Michel Josselin () and Benoît Le Maux ()
Additional contact information
Salah Ghabri: HAS - Haute Autorité de Santé [Saint-Denis La Plaine]
Jean-Michel Josselin: CREM - Centre de recherche en économie et management - UNICAEN - Université de Caen Normandie - NU - Normandie Université - UR - Université de Rennes - CNRS - Centre National de la Recherche Scientifique
Benoît Le Maux: CREM - Centre de recherche en économie et management - UNICAEN - Université de Caen Normandie - NU - Normandie Université - UR - Université de Rennes - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Keywords: Multiple criteria decision analysis; Economic evaluation; Health technology assessment; France (search for similar items in EconPapers)
Date: 2019-12
Note: View the original document on HAL open archive server: https://shs.hal.science/halshs-02319704
References: View references in EconPapers View complete reference list from CitEc
Citations:

Published in PharmacoEconomics, 2019, 37 (12), pp.1417-1419. ⟨10.1007/s40273-019-00846-w⟩

Downloads: (external link)
https://shs.hal.science/halshs-02319704/document (application/pdf)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:halshs-02319704

DOI: 10.1007/s40273-019-00846-w

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().